Home | Pause for thought
In this issue
NSF
Contents
Datwyler Company Insight
Datwyler
News
Baxter
Covid-19 executive briefing by GlobalData
ELPRO Monitoring Solutions
Abivax’s ABX464 enticing in theory for Covid-19 but mechanism, trial design issues belie potential for success
Abiomed’s Impella receives FDA Emergency Use Authorization during Covid-19
Fargo
Disruptions to global oncology trials have fallen to a three-month low
Mimotopes
AstraZeneca/Oxford University and CanSino publish promising Covid-19 vaccine cli
Biotech IPO valuation relies on data to enter capital markets during Covid-19 pa
Nelson Labs
The pharma industry briefing
Pfeiffer Vacuum
A century of cultures: celebrating the world’s oldest lab culture collection
Skyepharma
Gut feeling: exploring the therapeutic potential of the gut-brain axis
Optel
Crabby concoctions: why pharma’s thirst for crustacean blood is up for debate
Air France
Debunking myths about puberty blockers for transgender children
Micronova
Hiring from home: pharma recruitment in the age of Covid-19
Nipro Pharmapackaging
Q&A: breaking new ground in pharma packaging with Honeywell
Wipotec
Treatment-resistant rare diseases: exploring landmark drug approvals in 2020
VEGA Company Insight
VEGA Australia
Modernising pharma patents: can AI be an inventor?
ILC Dover
Boosting agility to accelerate project timescales
Scandinavian Health
Doing the right thing: the enhanced case for compliance
Deals in brief powered by GlobalData
The key list powered by GlobalData
Global markets and indices powered by GlobalData
Macro-economic indicators (1 of 2) powered by GlobalData
Macro-economic indicators (2 of 2) powered by GlobalData
Events
Next issue
08/24/2020 00:00:00
Go to article:
Home | Pause for thought
Go to article:
In this issue
Go to article:
NSF
Go to article:
Contents
Go to article:
Datwyler Company Insight
Go to article:
Datwyler
Go to article:
News
Go to article:
Baxter
Go to article:
Covid-19 executive briefing by GlobalData
Go to article:
ELPRO Monitoring Solutions
Go to article:
Abivax’s ABX464 enticing in theory for Covid-19 but mechanism, trial design issues belie potential for success
Go to article:
Abiomed’s Impella receives FDA Emergency Use Authorization during Covid-19
Go to article:
Fargo
Go to article:
Disruptions to global oncology trials have fallen to a three-month low
Go to article:
Mimotopes
Go to article:
AstraZeneca/Oxford University and CanSino publish promising Covid-19 vaccine cli
Go to article:
Biotech IPO valuation relies on data to enter capital markets during Covid-19 pa
Go to article:
Nelson Labs
Go to article:
The pharma industry briefing
Go to article:
Pfeiffer Vacuum
Go to article:
A century of cultures: celebrating the world’s oldest lab culture collection
Go to article:
Skyepharma
Go to article:
Gut feeling: exploring the therapeutic potential of the gut-brain axis
Go to article:
Optel
Go to article:
Crabby concoctions: why pharma’s thirst for crustacean blood is up for debate
Go to article:
Air France
Go to article:
Debunking myths about puberty blockers for transgender children
Go to article:
Micronova
Go to article:
Hiring from home: pharma recruitment in the age of Covid-19
Go to article:
Nipro Pharmapackaging
Go to article:
Q&A: breaking new ground in pharma packaging with Honeywell
Go to article:
Wipotec
Go to article:
Treatment-resistant rare diseases: exploring landmark drug approvals in 2020
Go to article:
VEGA Company Insight
Go to article:
VEGA Australia
Go to article:
Modernising pharma patents: can AI be an inventor?
Go to article:
ILC Dover
Go to article:
Boosting agility to accelerate project timescales
Go to article:
Scandinavian Health
Go to article:
Doing the right thing: the enhanced case for compliance
Go to article:
Deals in brief powered by GlobalData
Go to article:
The key list powered by GlobalData
Go to article:
Global markets and indices powered by GlobalData
Go to article:
Macro-economic indicators (1 of 2) powered by GlobalData
Go to article:
Macro-economic indicators (2 of 2) powered by GlobalData
Go to article:
Events
Go to article:
Next issue